ensembl_id string | gene string | gene_description string | uniprot list | chromosome string | position string | evidence string | hpa_evidence string | uniprot_evidence string | nextprot_evidence string | antibodies list | gene_synonyms list | protein_classes list | biological_processes list | molecular_functions list | disease_involvement list | subcellular_main_locations list | subcellular_additional_locations list | secretome_locations list | secretome_functions list | reliability_if string | reliability_ih string | reliability_mouse_brain string | interactions float64 | ccd_protein string | ccd_transcript string | blood_expression_cluster string | brain_expression_cluster string | cell_line_expression_cluster string | single_cell_expression_cluster string | tissue_expression_cluster string | rna_tissue_specificity string | rna_tissue_distribution string | rna_tissue_specificity_score float64 | rna_cell_line_specificity string | rna_cell_line_distribution string | rna_cell_line_specificity_score float64 | rna_cancer_specificity string | rna_cancer_distribution string | rna_cancer_specificity_score float64 | rna_single_cell_type_specificity string | rna_single_cell_type_distribution string | rna_single_cell_type_specificity_score float64 | rna_blood_cell_specificity string | rna_blood_cell_distribution string | rna_blood_cell_specificity_score float64 | prognostic_cancer_count int64 | validated_prognostic_cancer_count int64 | potential_prognostic_cancer_count int64 | favorable_prognostic_cancers list | unfavorable_prognostic_cancers list | prognostic_cancers list | source_row_index int64 | split_bucket int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENSG00000169020 | ATP5ME | ATP synthase membrane subunit e | [
"P56385"
] | 4 | 672436-674330 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA035010"
] | [
"ATP5I"
] | [
"Metabolic proteins",
"Predicted intracellular proteins",
"Transporters"
] | [
"ATP synthesis",
"Hydrogen ion transport",
"Ion transport",
"Transport"
] | [] | [] | [
"Mitochondria"
] | [] | [] | [] | Supported | Enhanced | null | 22 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 28: Oligodendrocytes - Mixed function | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 97: Non-specific - Cellular respiration | Cluster 52: Non-specific - Cellular respiration | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Colon Adenocarcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Colon Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | 12,257 | 2 |
ENSG00000169021 | UQCRFS1 | Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 | [
"P47985"
] | 19 | 29205320-29213151 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041863",
"HPA050339"
] | [
"RIP1",
"RIS1",
"RISP",
"UQCR5"
] | [
"Disease related genes",
"Enzymes",
"Essential proteins",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Electron transport",
"Respiratory chain",
"Transport"
] | [
"Translocase"
] | [
"Disease variant",
"Primary mitochondrial disease"
] | [
"Mitochondria"
] | [] | [] | [] | Approved | Enhanced | null | 58 | null | null | Cluster 26: Monocytes - Plasma membrane proteins | Cluster 23: Choroid plexus - Mixed function | Cluster 4: Non-specific - Transcription | Cluster 97: Non-specific - Cellular respiration | Cluster 52: Non-specific - Cellular respiration | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 12,258 | 1 |
ENSG00000169026 | SLC49A3 | Solute carrier family 49 member 3 | [
"Q6UXD7"
] | 4 | 681829-689271 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA043593"
] | [
"FLJ22269",
"LP2561",
"MFSD7"
] | [
"Predicted membrane proteins",
"Transporters"
] | [
"Transport"
] | [] | [] | [] | [] | [] | [] | null | Uncertain | null | null | null | null | null | Cluster 20: Macrophages & Microglia - Immune response | Cluster 7: Liver cancer - Metabolism | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 47: Testis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in single | null | 0 | 0 | 0 | [] | [] | [] | 12,259 | 8 |
ENSG00000169032 | MAP2K1 | Mitogen-activated protein kinase kinase 1 | [
"Q02750"
] | 15 | 66386837-66491656 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB003834",
"HPA026430",
"CAB080093"
] | [
"MAPKK1",
"MEK1",
"PRKMK1"
] | [
"Cancer-related genes",
"Disease related genes",
"Enzymes",
"FDA approved drug targets",
"Human disease related genes",
"Predicted intracellular proteins",
"RAS pathway related proteins"
] | [] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase",
"Tyrosine-protein kinase"
] | [
"Cancer-related genes",
"Cardiomyopathy",
"Disease variant",
"Ectodermal dysplasia",
"FDA approved drug targets",
"Intellectual disability"
] | [
"Plasma membrane",
"Cytosol"
] | [
"Basal body"
] | [] | [] | Supported | Approved | null | 69 | null | null | Cluster 44: Plasmacytoid DCs - Plasma membrane proteins | Cluster 51: Neurons - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | 12,261 | 3 |
ENSG00000169035 | KLK7 | Kallikrein related peptidase 7 | [
"P49862"
] | 19 | 50976468-50984099 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA018994",
"CAB026342",
"HPA062126"
] | [
"PRSS6",
"SCCE"
] | [
"Cancer-related genes",
"Enzymes",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [
"Hydrolase",
"Protease",
"Serine protease"
] | [
"Cancer-related genes"
] | [
"Plasma membrane"
] | [
"Nuclear membrane"
] | [
"Secreted in other tissues"
] | [
"Enzyme"
] | Supported | Enhanced | null | null | null | null | null | Cluster 24: Neurons - Mixed function | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 84: Apical squamous epithelium - Cornification | Cluster 58: Skin - Keratinization | Tissue enhanced | Detected in many | null | Group enriched | Detected in many | 5 | Cancer enhanced | Detected in many | null | Group enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Colon Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Colon Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 12,262 | 5 |
ENSG00000169045 | HNRNPH1 | Heterogeneous nuclear ribonucleoprotein H1 | [
"P31943"
] | 5 | 179614178-179634784 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA000914",
"HPA001359",
"HPA016884",
"CAB032820"
] | [
"hnRNPH",
"HNRPH1"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"mRNA processing",
"mRNA splicing"
] | [
"Ribonucleoprotein",
"RNA-binding"
] | [
"Disease variant",
"Intellectual disability"
] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | Supported | null | 289 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 15: Non-specific - Transcription | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 97: Non-specific - Cellular respiration | Cluster 44: Bone marrow - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma"
] | 12,263 | 5 |
ENSG00000169047 | IRS1 | Insulin receptor substrate 1 | [
"P35568"
] | 2 | 226731312-226799820 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB005261",
"HPA046433"
] | [
"HIRS-1"
] | [
"Disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Transducer"
] | [
"Diabetes mellitus",
"Disease variant"
] | [
"Nucleoplasm",
"Cytosol"
] | [
"Vesicles",
"Plasma membrane"
] | [] | [] | Approved | Uncertain | null | 58 | null | null | null | Cluster 2: Neurons - Nucleosome | Cluster 72: Neuronal - Signal transduction | Cluster 89: Adipocytes - Lipid metabolism | Cluster 75: Ovary - Mixed function | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Breast Invasive Carcinoma"
] | [] | [
"Breast Invasive Carcinoma"
] | 12,264 | 4 |
ENSG00000169057 | MECP2 | Methyl-CpG binding protein 2 | [
"P51608"
] | X | 154021573-154137103 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA000593",
"HPA001341",
"CAB037264"
] | [
"MRX16",
"MRX79",
"RTT"
] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding",
"Repressor"
] | [
"Autism",
"Autism spectrum disorder",
"Cancer-related genes",
"Disease variant",
"Intellectual disability"
] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Enhanced | null | 148 | null | null | Cluster 19: Eosinophils - Unknown function | Cluster 16: Non-specific - Transcription | Cluster 36: Non-specific - mRNA processing | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 24: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,265 | 4 |
ENSG00000169059 | VCX3A | Variable charge X-linked 3A | [
"Q9NNX9"
] | X | 6533618-6535118 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | [
"HPA044996",
"HPA049357"
] | [
"VCX-8r",
"VCX-A",
"VCX3"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Supported | null | null | null | null | null | null | Cluster 51: Myeloma - Immunoglobulins | Cluster 106: Spermatogonia - Spermatogonial differentiation | Cluster 79: Testis - Spermatogenesis | Tissue enriched | Detected in single | 130 | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 12,266 | 6 |
ENSG00000169062 | UPF3A | UPF3A regulator of nonsense mediated mRNA decay | [
"Q9H1J1"
] | 13 | 114281601-114305817 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA018325",
"HPA061316"
] | [
"HUPF3A",
"RENT3A",
"UPF3"
] | [
"Predicted intracellular proteins"
] | [
"mRNA transport",
"Nonsense-mediated mRNA decay",
"Transport"
] | [
"RNA-binding"
] | [] | [
"Nucleoplasm",
"Vesicles",
"Plasma membrane"
] | [
"Primary cilium",
"Primary cilium tip",
"Basal body"
] | [] | [] | Supported | Approved | null | 14 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 26: Oligodendrocytes - Mixed function | Cluster 19: Non-specific - Unknown function | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 67: Testis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in many | null | 2 | 2 | 1 | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 12,267 | 5 |
ENSG00000169064 | ZBBX | Zinc finger B-box domain containing | [
"A8MT70"
] | 3 | 167239843-167407874 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA036327",
"HPA036328"
] | [
"FLJ23049"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Golgi apparatus"
] | [] | [] | [] | Approved | Enhanced | null | null | null | null | null | Cluster 17: Choroid plexus - Cilium | Cluster 10: Ciliated cells - Ion channel activity | Cluster 34: Ciliated cells - Cilia assembly & function | Cluster 56: Ciliated tissues - Cilium organization | Group enriched | Detected in some | 7 | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in single | null | Group enriched | Detected in some | 6 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,268 | 1 |
ENSG00000169071 | ROR2 | Receptor tyrosine kinase like orphan receptor 2 | [
"Q01974"
] | 9 | 91563091-91950228 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"BDB",
"BDB1",
"NTRKR2"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted membrane proteins"
] | [
"Wnt signaling pathway"
] | [
"Developmental protein",
"Kinase",
"Receptor",
"Transferase",
"Tyrosine-protein kinase"
] | [
"Disease variant",
"Dwarfism"
] | [] | [] | [] | [] | null | null | null | 65 | null | null | null | Cluster 36: Choroid plexus - Mixed function | Cluster 20: Myeloma - Immune response | Cluster 101: Choroid plexus epithelial cells - Ion transport | Cluster 1: Choroid plexus - Transmembrane transport | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in single | 6 | 1 | 0 | 1 | [] | [
"Thyroid Carcinoma"
] | [
"Thyroid Carcinoma"
] | 12,270 | 1 |
ENSG00000169083 | AR | Androgen receptor | [
"P10275"
] | X | 67544021-67730619 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB000001",
"HPA004733",
"CAB065764"
] | [
"AIS",
"DHTR",
"HUMARA",
"NR3C4",
"SBMA",
"SMAX1"
] | [
"Cancer-related genes",
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Nuclear receptors",
"Plasma proteins",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding",
"Receptor"
] | [
"Cancer-related genes",
"Disease variant",
"FDA approved drug targets",
"Neurodegeneration",
"Pseudohermaphroditism"
] | [
"Cytosol"
] | [] | [] | [] | Supported | Enhanced | null | 330 | null | null | null | Cluster 41: Monoamines - Neurotransmitter signalling | Cluster 60: Prostate cancer - Unknown function | Cluster 16: Prostatic glandular cells - Androgen response & seminal fluid | Cluster 16: Liver & Kidney - Metabolism | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in many | 11 | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,271 | 2 |
ENSG00000169084 | DHRSX | Dehydrogenase/reductase X-linked | [
"Q8N5I4"
] | X | 2219506-2502805 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA003035",
"HPA075955"
] | [
"DHRS5X",
"DHRS5Y",
"DHRSXY",
"DHRSY",
"SDR46C1",
"SDR7C6"
] | [
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [
"Oxidoreductase"
] | [
"Congenital disorder of glycosylation",
"Disease variant"
] | [
"Cytosol"
] | [
"Mitotic spindle"
] | [
"Secreted to blood"
] | [
"Enzyme"
] | Uncertain | Approved | null | 15 | Yes | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 46: Brainstem - Mixed function | Cluster 36: Non-specific - mRNA processing | Cluster 31: Neutrophils - Chemotaxis & Apoptosis | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | 12,272 | 8 |
ENSG00000169085 | VXN | Vexin | [
"Q8TAG6"
] | 8 | 66492326-66518524 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA075134"
] | [
"C8orf46",
"MGC33510"
] | [
"Predicted intracellular proteins"
] | [
"Neurogenesis"
] | [] | [] | [
"Nuclear speckles"
] | [] | [] | [] | Approved | null | null | 5 | null | null | null | Cluster 51: Neurons - Mixed function | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 35: Neurons - Synaptic function & neurogenesis | Cluster 3: Oligodendrocytes - Myelination | Tissue enriched | Detected in many | 13 | Cancer enhanced | Detected in many | null | Cancer enriched | Detected in some | 5 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,273 | 5 |
ENSG00000169087 | HSPBAP1 | HSPB1 associated protein 1 | [
"Q96EW2"
] | 3 | 122739999-122793831 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA044930"
] | [
"FLJ22623",
"PASS1"
] | [
"Disease related genes",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Mitochondria"
] | [] | [] | [] | Approved | Approved | null | 8 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 49: Hindbrain - Mixed function | Cluster 63: Non-specific - Protein processing | Cluster 24: Neutrophils - Innate immunity signal integration | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 12,274 | 2 |
ENSG00000169093 | ASMTL | Acetylserotonin O-methyltransferase like | [
"O95671"
] | X | 1403139-1453762 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA003630",
"HPA021865"
] | [] | [
"Enzymes",
"Predicted intracellular proteins"
] | [
"Nucleotide metabolism"
] | [
"Hydrolase",
"Methyltransferase",
"Transferase"
] | [] | [
"Cytosol"
] | [] | [] | [] | Enhanced | Supported | null | 11 | null | null | Cluster 22: Eosinophils - Transcription | Cluster 44: Non-specific - Mixed function | Cluster 55: Lymphoma - Immune response | Cluster 82: Dendritic cells - Antigen presentation | Cluster 75: Ovary - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,275 | 2 |
ENSG00000169100 | SLC25A6 | Solute carrier family 25 member 6 | [
"P12236"
] | X | 1386152-1392113 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA046835",
"HPA071684"
] | [
"ANT3",
"ANT3Y",
"MGC17525"
] | [
"FDA approved drug targets",
"Metabolic proteins",
"Plasma proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Antiport",
"Apoptosis",
"Host-virus interaction",
"Transport"
] | [] | [
"FDA approved drug targets"
] | [
"Mitochondria"
] | [] | [] | [] | Approved | Approved | null | 94 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 23: Choroid plexus - Mixed function | Cluster 25: Non-specific - Ribosome | Cluster 15: Non-specific - Protein processing | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Pancreatic Adenocarcinoma"
] | [] | [
"Pancreatic Adenocarcinoma"
] | 12,276 | 9 |
ENSG00000169105 | CHST14 | Carbohydrate sulfotransferase 14 | [
"Q8NCH0"
] | 15 | 40470984-40473158 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA057697",
"HPA071601"
] | [
"D4ST-1",
"D4ST1",
"HD4ST"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted membrane proteins"
] | [
"Carbohydrate metabolism"
] | [
"Transferase"
] | [
"Disease variant",
"Ehlers-Danlos syndrome"
] | [
"Golgi apparatus"
] | [] | [] | [] | Approved | Enhanced | null | 25 | null | null | Cluster 45: Eosinophils - Unknown function | Cluster 44: Non-specific - Mixed function | Cluster 15: Kidney cancer - Membrane components | Cluster 63: Cytotrophoblasts - Basic cellular functions | Cluster 75: Ovary - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 12,277 | 7 |
ENSG00000169116 | PARM1 | Prostate androgen-regulated mucin-like protein 1 | [
"Q6UWI2"
] | 4 | 74933095-75050115 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038236"
] | [
"Cipar1",
"DKFZP564O0823",
"WSC4"
] | [
"Predicted membrane proteins"
] | [] | [] | [] | [
"Nucleoplasm",
"Vesicles",
"Cytosol"
] | [] | [] | [] | Approved | Approved | null | 1 | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 55: Lymphoma - Immune response | Cluster 45: Colonocytes & Enterocytes - Gastrointestinal absorption & barrier | Cluster 69: Parathyroid gland - Mixed function | Low tissue specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in some | 15 | 3 | 2 | 2 | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Thyroid Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Thyroid Carcinoma"
] | 12,278 | 6 |
ENSG00000169118 | CSNK1G1 | Casein kinase 1 gamma 1 | [
"Q9HCP0"
] | 15 | 64165525-64356173 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA018209"
] | [
"CK1gamma1"
] | [
"Enzymes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Wnt signaling pathway"
] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [] | [
"Cytosol"
] | [] | [] | [] | Supported | null | null | 8 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 29: Forebrain - Mixed function | Cluster 58: Non-specific - Nuclear processes | Cluster 22: Non-specific - Basic cellular functions | Cluster 47: Testis - Mixed function | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma"
] | 12,279 | 2 |
ENSG00000169122 | FAM110B | Family with sequence similarity 110 member B | [
"Q8TC76"
] | 8 | 57994523-58204279 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA008318",
"HPA011781"
] | [
"C8orf72",
"MGC39325"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Mitochondria",
"Cytosol"
] | [] | [] | [] | Supported | Uncertain | null | 8 | null | null | Cluster 40: Monocytes - Innate immune response | Cluster 1: Neurons - Mixed function | Cluster 3: Rhabdoid - Membrane components | Cluster 109: Neurons - Neuronal signaling | Cluster 48: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in some | 6 | 3 | 0 | 3 | [
"Glioblastoma Multiforme",
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [] | [
"Glioblastoma Multiforme",
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 12,280 | 7 |
ENSG00000169126 | ODAD2 | Outer dynein arm docking complex subunit 2 | [
"Q5T2S8"
] | 10 | 27775186-27999079 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA037829"
] | [
"ARMC4",
"CILD23",
"DKFZP434P1735",
"FLJ10376",
"FLJ10817",
"gudu"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Cilium biogenesis/degradation"
] | [] | [
"Ciliopathy",
"Kartagener syndrome",
"Primary ciliary dyskinesia"
] | [
"End piece"
] | [
"Acrosome",
"Principal piece"
] | [] | [] | Approved | Enhanced | null | 11 | null | null | null | Cluster 3: Choroid plexus - Cilium | Cluster 11: Neuronal - Sensory perception | Cluster 34: Ciliated cells - Cilia assembly & function | Cluster 56: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,281 | 1 |
ENSG00000169129 | AFAP1L2 | Actin filament associated protein 1 like 2 | [
"Q8N4X5"
] | 10 | 114294824-114404756 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA037843"
] | [
"Em:AC005383.4",
"FLJ14564",
"KIAA1914",
"XB130"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Cytosol"
] | [
"Plasma membrane"
] | [] | [] | Supported | Approved | null | 1 | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 15: Non-specific - Transcription | Cluster 15: Kidney cancer - Membrane components | Cluster 104: Brain endothelial cells - Blood brain barrier | Cluster 33: Thyroid gland - Tissue development | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 12,282 | 6 |
ENSG00000169131 | ZNF354A | Zinc finger protein 354A | [
"O60765"
] | 5 | 178711512-178730659 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA052043"
] | [
"EZNF",
"HKL1",
"KID-1",
"KID1",
"TCF17"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [] | [
"Nucleoplasm",
"Nucleoli"
] | [
"Cytosol"
] | [] | [] | Supported | Approved | null | 7 | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 34: Non-specific - Mixed function | Cluster 4: Non-specific - Transcription | Cluster 48: Neutrophils - Phagocytosis & degranulation | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe"
] | 12,283 | 3 |
ENSG00000169136 | ATF5 | Activating transcription factor 5 | [
"Q9Y2D1"
] | 19 | 49928702-49933935 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA030187"
] | [] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Vesicles",
"Cytosol"
] | [] | [] | Supported | Uncertain | null | 13 | null | null | Cluster 2: Dendritic cells - Unknown function | Cluster 41: Monoamines - Neurotransmitter signalling | Cluster 55: Lymphoma - Immune response | Cluster 25: Hepatocytes - Plasma protein synthesis & secretion | Cluster 31: Liver - Metabolism & Coagulation | Tissue enriched | Detected in all | 21 | Cancer enhanced | Detected in all | null | Cancer enriched | Detected in all | 5 | Cell type enriched | Detected in many | 4 | Immune cell enhanced | Detected in many | null | 1 | 0 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,284 | 2 |
ENSG00000169139 | UBE2V2 | Ubiquitin conjugating enzyme E2 V2 | [
"Q15819"
] | 8 | 48008415-48064708 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA052535",
"HPA053186"
] | [
"DDVit-1",
"DDVIT1",
"EDAF-1",
"EDPF-1",
"EDPF1",
"MMS2",
"UEV-2",
"UEV2"
] | [
"Predicted intracellular proteins"
] | [
"Ubl conjugation pathway"
] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | null | null | 12 | null | null | Cluster 1: T-cells - Unknown function | Cluster 14: Neurons - Synaptic function | Cluster 40: Non-specific - Unknown function | Cluster 85: Squamous epithelial cells - Keratinization | Cluster 10: Brain - Synaptic signal transduction | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 6 | 0 | 6 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 12,285 | 4 |
ENSG00000169154 | GOT1L1 | Glutamic-oxaloacetic transaminase 1 like 1 | [
"Q8NHS2"
] | 8 | 37934281-37940124 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA028778"
] | [
"MGC33309"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [] | [
"Aminotransferase",
"Transferase"
] | [] | [] | [] | [] | [] | null | Uncertain | null | null | null | null | null | Cluster 51: Neurons - Mixed function | Cluster 12: Bone cancer - Neuronal signaling | Cluster 42: Early spermatids - Spermiogenesis: Acrosomal phase | Cluster 6: Testis - Spermatogenesis | Tissue enriched | Detected in single | 32 | Not detected | Not detected | null | Not detected | Not detected | null | Group enriched | Detected in some | 6 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,286 | 3 |
ENSG00000169169 | CPT1C | Carnitine palmitoyltransferase 1C | [
"Q8TCG5"
] | 19 | 49690898-49713731 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA063621"
] | [
"CATL1",
"CPT1P",
"CPTIC",
"FLJ23809"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Fatty acid metabolism",
"Lipid metabolism"
] | [
"Acyltransferase",
"Hydrolase",
"Transferase"
] | [
"Disease variant",
"Hereditary spastic paraplegia",
"Neurodegeneration"
] | [] | [] | [] | [] | null | Approved | null | null | null | null | null | Cluster 23: Choroid plexus - Mixed function | Cluster 5: Rhabdoid - Unknown function | Cluster 86: Retinal bipolar cells - Synaptic signal transduction | Cluster 1: Choroid plexus - Transmembrane transport | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Pancreatic Adenocarcinoma"
] | [] | [
"Pancreatic Adenocarcinoma"
] | 12,288 | 3 |
ENSG00000169180 | XPO6 | Exportin 6 | [
"Q96QU8"
] | 16 | 28097976-28211965 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038246"
] | [
"FLJ22519",
"KIAA0370",
"RANBP20"
] | [
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Protein transport",
"Transport"
] | [] | [] | [
"Nucleoplasm",
"Nucleoli"
] | [
"Plasma membrane",
"Cytosol"
] | [] | [] | Supported | Uncertain | null | 11 | No | No | Cluster 21: Neutrophils - Unknown function | Cluster 27: Non-specific - Mixed function | Cluster 54: Non-specific - Transcription | Cluster 24: Neutrophils - Innate immunity signal integration | Cluster 5: Spleen - Immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in all | 10 | Immune cell enriched | Detected in all | 6 | 4 | 2 | 3 | [
"Glioblastoma Multiforme"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 12,290 | 3 |
ENSG00000169181 | GSG1L | GSG1 like | [
"Q6UXU4"
] | 16 | 27787528-28063714 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA014479"
] | [
"KTSR5831",
"MGC18079",
"PRO19651"
] | [
"Predicted membrane proteins",
"Transporters"
] | [] | [] | [] | [] | [] | [] | [] | null | Enhanced | null | 1 | null | null | null | Cluster 38: Sub-cortical - Mixed function | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 35: Neurons - Synaptic function & neurogenesis | Cluster 35: Non-specific - Mixed function | Group enriched | Detected in some | 9 | Cancer enriched | Detected in single | 7 | Cancer enriched | Detected in some | 4 | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,291 | 5 |
ENSG00000169184 | MN1 | MN1 proto-oncogene, transcriptional regulator | [
"Q10571"
] | 22 | 27748277-27801756 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA003072"
] | [
"MGCR",
"MGCR1",
"MGCR1-PEN"
] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Developmental protein"
] | [
"Cancer-related genes",
"Disease variant",
"Intellectual disability",
"Tumor suppressor"
] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Approved | null | 4 | null | null | null | Cluster 33: Neurons - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 36: Skeletal myocytes - Muscle excitation & contraction | Cluster 19: Skeletal muscle - Striated muscle contraction | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Glioblastoma Multiforme"
] | [] | [
"Glioblastoma Multiforme"
] | 12,292 | 6 |
ENSG00000169188 | APEX2 | Apurinic/apyrimidinic endodeoxyribonuclease 2 | [
"Q9UBZ4"
] | X | 55000363-55009057 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA048577"
] | [
"APE2",
"APEXL2",
"XTH2",
"ZGRF2"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [
"Cell cycle",
"DNA damage",
"DNA recombination",
"DNA repair"
] | [
"DNA-binding",
"Endonuclease",
"Exonuclease",
"Hydrolase",
"Nuclease"
] | [] | [
"Nucleoplasm",
"Nucleoli fibrillar center"
] | [
"Vesicles"
] | [] | [] | Supported | null | null | 6 | null | Yes | Cluster 12: Non-specific - Mitochondrial translation | Cluster 27: Non-specific - Mixed function | Cluster 36: Non-specific - mRNA processing | Cluster 63: Cytotrophoblasts - Basic cellular functions | Cluster 11: Esophagus - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 12,293 | 9 |
ENSG00000169189 | NSMCE1 | NSE1 homolog, SMC5-SMC6 complex component | [
"Q8WV22"
] | 16 | 27224994-27268772 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041567",
"HPA043091"
] | [
"NSE1"
] | [
"Enzymes",
"Essential proteins",
"Predicted intracellular proteins"
] | [
"DNA damage",
"DNA recombination",
"DNA repair",
"Ubl conjugation pathway"
] | [
"Transferase"
] | [] | [
"Nucleoplasm"
] | [
"Vesicles"
] | [] | [] | Supported | Supported | null | 32 | null | null | Cluster 41: Basophils - Unknown function | Cluster 21: Non-specific - Metabolism | Cluster 35: RS4;11 - Unknown function | Cluster 56: Late spermatids - Spermiogenesis: Maturation | Cluster 56: Ciliated tissues - Cilium organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Head and Neck Squamous Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma"
] | 12,294 | 6 |
ENSG00000169193 | CCDC126 | Coiled-coil domain containing 126 | [
"Q96EE4"
] | 7 | 23597382-23644708 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA010969",
"HPA026883"
] | [
"FLJ23031"
] | [
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [] | [] | [
"Golgi apparatus"
] | [] | [
"Secreted to blood"
] | [
"No annotated function"
] | Approved | Uncertain | null | 1 | null | null | Cluster 46: Basophils - Proteolysis | Cluster 25: Non-specific - Transcription | Cluster 67: Non-specific - Unknown function | Cluster 48: Neutrophils - Phagocytosis & degranulation | Cluster 6: Testis - Spermatogenesis | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Group enriched | Detected in many | 4 | Immune cell enriched | Detected in all | 6 | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 12,295 | 3 |
ENSG00000169194 | IL13 | Interleukin 13 | [
"P35225"
] | 5 | 132656263-132661110 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"ALRH",
"BHR1",
"IL-13",
"MGC116786",
"MGC116788",
"MGC116789",
"P600"
] | [
"Cancer-related genes",
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Plasma proteins",
"Predicted secreted proteins"
] | [] | [
"Cytokine"
] | [
"Cancer-related genes",
"FDA approved drug targets"
] | [] | [] | [
"Secreted to blood"
] | [
"Interleukin"
] | null | null | null | 10 | null | null | null | null | Cluster 59: Leukemia - T-cell receptor | Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization | Cluster 23: Testis - Spermatogenesis | Tissue enriched | Detected in single | 45 | Cancer enriched | Detected in single | 45 | Not detected | Not detected | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,296 | 1 |
ENSG00000169203 | NPIPB12 | Nuclear pore complex interacting protein family member B12 | [
"F8W0I5"
] | 16 | 29483534-29506408 | Evidence at protein level | Evidence at protein level | No human protein/transcript evidence | Evidence at transcript level | [
"HPA053611"
] | [] | [
"Predicted membrane proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Approved | null | null | null | null | null | Cluster 4: Non-specific - mRNA splicing & Cell cycle | Cluster 56: Non-specific - Sensory perception | Cluster 105: Non-specific - Mixed function | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Group enriched | Detected in some | 6 | Immune cell enhanced | Detected in single | null | 2 | 0 | 2 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 12,297 | 4 |
ENSG00000169208 | OR10G3 | Olfactory receptor family 10 subfamily G member 3 | [
"Q8NGC4"
] | 14 | 21568520-21580076 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [
"HPA019766"
] | [] | [
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [
"Olfaction",
"Sensory transduction"
] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [] | [] | [] | [] | [] | null | Uncertain | null | null | null | null | null | Cluster 10: Cerebellum - Nucleic acid binding | Cluster 56: Non-specific - Sensory perception | Cluster 59: Pituitary endocrine cells - Neuroendocrine signaling | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Cell type enriched | Detected in some | 11 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,298 | 5 |
ENSG00000169213 | RAB3B | RAB3B, member RAS oncogene family | [
"P20337"
] | 1 | 51907956-51990700 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA003159",
"CAB023293"
] | [] | [
"Predicted intracellular proteins"
] | [
"Protein transport",
"Transport"
] | [
"Hydrolase"
] | [] | [
"Cell Junctions"
] | [] | [] | [] | Approved | Enhanced | null | 21 | null | null | null | Cluster 1: Neurons - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 76: Pancreatic endocrine cells - Endocrine signaling | Cluster 36: Brain & Liver - Signaling | Tissue enhanced | Detected in some | null | Low cancer specificity | Detected in many | null | Group enriched | Detected in many | 6 | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Lung Squamous Cell Carcinoma"
] | [] | [
"Lung Squamous Cell Carcinoma"
] | 12,299 | 3 |
ENSG00000169214 | OR6F1 | Olfactory receptor family 6 subfamily F member 1 | [
"Q8NGZ6"
] | 1 | 247711436-247716646 | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | Evidence at transcript level | [] | [
"OST731"
] | [
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [
"Olfaction",
"Sensory transduction"
] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | null | null | Cluster 72: Neuronal - Signal transduction | Cluster 77: Late primary spermatocytes - Spermiogenesis: Golgi Phase | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Group enriched | Detected in some | 7 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,300 | 5 |
ENSG00000169217 | CD2BP2 | CD2 cytoplasmic tail binding protein 2 | [
"O95400"
] | 16 | 30350773-30355308 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041508",
"HPA061309"
] | [
"LIN1",
"PPP1R59",
"Snu40",
"U5-52K"
] | [
"Predicted intracellular proteins"
] | [
"mRNA processing",
"mRNA splicing"
] | [] | [] | [
"Nuclear speckles"
] | [
"Cytosol"
] | [] | [] | Enhanced | Enhanced | null | 159 | Yes | No | Cluster 36: Eosinophils - Protein ubiquitination | Cluster 27: Non-specific - Mixed function | Cluster 54: Non-specific - Transcription | Cluster 97: Non-specific - Cellular respiration | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 12,301 | 1 |
ENSG00000169218 | RSPO1 | R-spondin 1 | [
"Q2MKA7"
] | 1 | 37611350-37634892 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA046154",
"HPA062923"
] | [
"FLJ40906",
"RSPONDIN"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"Sensory transduction",
"Wnt signaling pathway"
] | [
"Heparin-binding"
] | [
"Palmoplantar keratoderma"
] | [
"Vesicles"
] | [] | [
"Secreted in female reproductive system"
] | [
"Other"
] | Approved | Uncertain | null | 6 | null | null | null | Cluster 48: Non-specific - Mixed function | Cluster 27: Breast cancer - Unknown function | Cluster 108: Fibroblasts - ECM organization | Cluster 75: Ovary - Mixed function | Tissue enhanced | Detected in many | null | Not detected | Not detected | null | Cancer enriched | Detected in some | 8 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,302 | 6 |
ENSG00000169220 | RGS14 | Regulator of G protein signaling 14 | [
"O43566"
] | 5 | 177357924-177372596 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA046847",
"HPA061819"
] | [] | [
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division"
] | [
"GTPase activation",
"Signal transduction inhibitor"
] | [] | [
"Nucleoplasm",
"Plasma membrane"
] | [
"Vesicles"
] | [] | [] | Uncertain | Approved | null | 7 | No | No | Cluster 21: Neutrophils - Unknown function | Cluster 33: Neurons - Mixed function | Cluster 70: DU4475 - Unknown function | Cluster 85: Squamous epithelial cells - Keratinization | Cluster 78: Brain - Neuronal signaling | Tissue enriched | Detected in many | 8 | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Glioblastoma Multiforme",
"Pancreatic Adenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Pancreatic Adenocarcinoma"
] | 12,303 | 4 |
ENSG00000169221 | TBC1D10B | TBC1 domain family member 10B | [
"Q4KMP7"
] | 16 | 30357102-30370494 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA048894"
] | [
"DKFZP434P1750",
"EPI64B",
"FLJ13130",
"Rab27A-GAPbeta"
] | [
"Predicted intracellular proteins"
] | [] | [
"GTPase activation"
] | [] | [] | [] | [] | [] | null | Uncertain | null | 7 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 27: Non-specific - Mixed function | Cluster 54: Non-specific - Transcription | Cluster 48: Neutrophils - Phagocytosis & degranulation | Cluster 67: Testis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in some | null | 2 | 0 | 2 | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 12,304 | 6 |
ENSG00000169223 | LMAN2 | Lectin, mannose binding 2 | [
"Q12907"
] | 5 | 177315805-177351840 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA003927",
"CAB033812"
] | [
"C5orf8",
"GP36B",
"VIP36"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Protein transport",
"Transport"
] | [] | [] | [
"Golgi apparatus"
] | [] | [] | [] | Supported | Approved | null | 25 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 36: Choroid plexus - Mixed function | Cluster 63: Non-specific - Protein processing | Cluster 8: Non-specific - Secretory pathway | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 12,305 | 9 |
ENSG00000169224 | GCSAML | Germinal center associated signaling and motility like | [
"Q5JQS6"
] | 1 | 247507058-247577690 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA027507",
"HPA027510"
] | [
"C1orf150",
"FLJ44728"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Cytosol"
] | [] | [] | [] | Approved | Uncertain | null | 7 | null | null | Cluster 46: Basophils - Proteolysis | Cluster 35: Non-specific - DNA binding | Cluster 49: HMC-1 - Innate immune response | Cluster 58: Mast cells - Allergic inflammatory responses | Cluster 64: Non-specific - Transcription | Tissue enhanced | Detected in some | null | Cancer enriched | Detected in some | 13 | Cancer enriched | Detected in single | 7 | Cell type enhanced | Detected in some | null | Immune cell enriched | Detected in single | 670 | 0 | 0 | 0 | [] | [] | [] | 12,306 | 6 |
ENSG00000169228 | RAB24 | RAB24, member RAS oncogene family | [
"Q969Q5"
] | 5 | 177301198-177303744 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA078320"
] | [] | [
"Predicted intracellular proteins"
] | [
"Autophagy",
"Protein transport",
"Transport"
] | [
"Hydrolase"
] | [] | [
"Cytosol"
] | [] | [] | [] | Supported | null | null | 20 | null | No | Cluster 7: Non-specific - Innate immune response | Cluster 24: Neurons - Mixed function | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 98: Neurons - Neurotransmission & signaling | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [] | [
"Glioblastoma Multiforme",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 12,307 | 5 |
ENSG00000169230 | PRELID1 | PRELI domain containing 1 | [
"Q9Y255"
] | 5 | 177303799-177306949 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA005701"
] | [
"CGI-106",
"PRELI",
"PX19"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Apoptosis",
"Lipid transport",
"Transport"
] | [] | [] | [
"Mitochondria"
] | [
"Nucleoplasm"
] | [] | [] | Supported | Approved | null | 12 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 45: Non-specific - Mixed function | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 45: Colonocytes & Enterocytes - Gastrointestinal absorption & barrier | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 12,308 | 3 |
ENSG00000169231 | THBS3 | Thrombospondin 3 | [
"P49746"
] | 1 | 155195588-155209051 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA006293",
"HPA073242"
] | [] | [
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"Cell adhesion"
] | [] | [] | [
"Vesicles"
] | [] | [
"Secreted to extracellular matrix"
] | [
"Cell adhesion"
] | Approved | Approved | null | 3 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 17: Choroid plexus - Cilium | Cluster 5: Rhabdoid - Unknown function | Cluster 73: Late spermatids - Spermiogenesis: Maturation | Cluster 12: Smooth muscle tissue - ECM organization | Low tissue specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in many | 4 | Low immune cell specificity | Detected in some | null | 1 | 0 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,309 | 1 |
ENSG00000169239 | CA5B | Carbonic anhydrase 5B | [
"Q9Y2D0"
] | X | 15688830-15788411 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA012618"
] | [] | [
"Enzymes",
"FDA approved drug targets",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [] | [
"Lyase"
] | [
"FDA approved drug targets"
] | [
"Mitochondria"
] | [] | [] | [] | Supported | Uncertain | null | 1 | null | null | Cluster 1: T-cells - Unknown function | Cluster 41: Monoamines - Neurotransmitter signalling | Cluster 27: Breast cancer - Unknown function | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 55: Breast - Lactation | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 12,310 | 8 |
ENSG00000169241 | SLC50A1 | Solute carrier family 50 member 1 | [
"Q9BRV3"
] | 1 | 155135344-155138857 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA018095"
] | [
"HsSWEET1",
"RAG1AP1",
"RP11-540D14.5",
"RZPDo834D038D",
"SCP",
"slv",
"SWEET1"
] | [
"Predicted membrane proteins",
"Transporters"
] | [
"Sugar transport",
"Transport"
] | [] | [] | [] | [] | [] | [] | null | Enhanced | null | 3 | null | null | Cluster 32: Basophils - Transcription | Cluster 44: Non-specific - Mixed function | Cluster 45: Non-specific - Nuclear processes | Cluster 4: Breast lactating luminal cells - Lactation | Cluster 22: Epididymis - Mixed function | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | 12,311 | 6 |
ENSG00000169242 | EFNA1 | Ephrin A1 | [
"P20827"
] | 1 | 155127876-155134899 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA069549"
] | [
"ECKLG",
"EPLG1",
"GMAN",
"LERK1",
"TNFAIP4"
] | [
"Cancer-related genes",
"Predicted secreted proteins",
"RAS pathway related proteins"
] | [
"Angiogenesis"
] | [] | [
"Cancer-related genes",
"Tumor suppressor"
] | [] | [] | [
"Secreted to blood"
] | [
"Developmental protein"
] | null | Approved | null | 7 | null | Yes | Cluster 43: Non-specific - Transcription & Translation | Cluster 11: White matter - Signal transduction | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 21: Extravillous trophoblasts - Placental invasion & endocrine regulatio | Cluster 31: Liver - Metabolism & Coagulation | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in some | 8 | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,312 | 9 |
ENSG00000169245 | CXCL10 | C-X-C motif chemokine ligand 10 | [
"P02778"
] | 4 | 76021118-76023497 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"C7",
"crg-2",
"gIP-10",
"IFI10",
"INP10",
"IP-10",
"mob-1",
"SCYB10"
] | [
"Cancer-related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted secreted proteins"
] | [
"Chemotaxis",
"Inflammatory response"
] | [
"Cytokine"
] | [
"Cancer-related genes"
] | [] | [] | [
"Secreted to blood"
] | [
"Chemokine"
] | null | null | null | 4 | null | null | Cluster 40: Monocytes - Innate immune response | Cluster 43: Hindbrain - Mixed function | Cluster 55: Lymphoma - Immune response | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 18: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Group enriched | Detected in many | 6 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in many | 11 | 3 | 0 | 3 | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 12,313 | 8 |
ENSG00000169246 | NPIPB3 | Nuclear pore complex interacting protein family member B3 | [
"Q92617"
] | 16 | 21402237-21448567 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA053611"
] | [
"KIAA0220",
"NPIPL3"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Approved | null | null | null | null | Cluster 20: Non-specific - DNA binding | Cluster 4: Non-specific - mRNA splicing & Cell cycle | Cluster 56: Non-specific - Sensory perception | Cluster 102: Non-specific - Mixed function | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Immune cell enhanced | Detected in all | null | 2 | 0 | 2 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 12,314 | 3 |
ENSG00000169247 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | [
"Q8TF17"
] | 5 | 148923639-149063163 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA037683",
"HPA037684"
] | [
"CMT4C",
"KIAA1985"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [] | [
"Charcot-Marie-Tooth disease",
"Disease variant",
"Neurodegeneration",
"Neuropathy"
] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | [] | Approved | Uncertain | null | null | No | No | null | Cluster 11: White matter - Signal transduction | Cluster 69: Skin cancer - ECM organization | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 3: Oligodendrocytes - Myelination | Group enriched | Detected in some | 7 | Cancer enhanced | Detected in some | null | Not detected | Not detected | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,315 | 2 |
ENSG00000169248 | CXCL11 | C-X-C motif chemokine ligand 11 | [
"O14625"
] | 4 | 76033682-76041415 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"CAB009921"
] | [
"b-R1",
"H174",
"I-TAC",
"IP-9",
"SCYB11",
"SCYB9B"
] | [
"Human disease related genes",
"Predicted secreted proteins"
] | [
"Chemotaxis",
"Inflammatory response"
] | [
"Cytokine"
] | [] | [] | [] | [
"Secreted to blood"
] | [
"Chemokine"
] | null | Uncertain | null | 5 | null | null | null | Cluster 47: Endothelial cells - Vasculature | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [
"Ovary Serous Cystadenocarcinoma",
"Rectum Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Ovary Serous Cystadenocarcinoma",
"Pancreatic Adenocarcinoma",
"Rectum Adenocarcinoma"
] | 12,316 | 8 |
ENSG00000169249 | ZRSR2 | Zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 | [
"Q15696"
] | X | 15790156-15830694 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"U2AF1-RS2",
"U2AF1L2",
"URP",
"ZC3H22"
] | [
"Cancer-related genes",
"Essential proteins",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"mRNA processing",
"mRNA splicing"
] | [
"Ribonucleoprotein",
"RNA-binding"
] | [
"Cancer-related genes",
"Ciliopathy"
] | [] | [] | [] | [] | null | null | null | 46 | null | null | Cluster 45: Eosinophils - Unknown function | Cluster 4: Non-specific - mRNA splicing & Cell cycle | Cluster 36: Non-specific - mRNA processing | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe"
] | 12,317 | 5 |
ENSG00000169251 | NMD3 | NMD3 ribosome export adaptor | [
"Q96D46"
] | 3 | 161104696-161253532 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA035019"
] | [
"CGI-07"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"Protein transport",
"Transport"
] | [] | [] | [
"Nucleoplasm",
"Nucleoli"
] | [] | [] | [] | Supported | null | null | 17 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 16: Non-specific - Transcription | Cluster 63: Non-specific - Protein processing | Cluster 60: Cardiomyocytes - Cardiac muscle contraction & structure | Cluster 45: Liver - Metabolism & Coagulation | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 4 | 2 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Lung Adenocarcinoma",
"Ovary Serous Cystadenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma",
"Ovary Serous Cystadenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 12,318 | 8 |
ENSG00000169255 | B3GALNT1 | Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) | [
"O75752"
] | 3 | 161083883-161105411 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041204"
] | [
"B3GALANT1",
"B3GALT3",
"beta3Gal-T3",
"galT3",
"GLOB"
] | [
"Blood group antigen proteins",
"Enzymes",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Lipid metabolism"
] | [
"Blood group antigen",
"Glycosyltransferase",
"Transferase"
] | [] | [
"Vesicles"
] | [] | [] | [] | Approved | null | null | null | null | null | Cluster 32: Basophils - Transcription | Cluster 1: Neurons - Mixed function | Cluster 27: Breast cancer - Unknown function | Cluster 60: Cardiomyocytes - Cardiac muscle contraction & structure | Cluster 35: Non-specific - Mixed function | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in some | 7 | 3 | 2 | 2 | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 12,320 | 9 |
ENSG00000169258 | GPRIN1 | G protein regulated inducer of neurite outgrowth 1 | [
"Q7Z2K8"
] | 5 | 176595802-176610156 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA036478",
"HPA070892"
] | [
"GRIN1",
"KIAA1893"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Plasma membrane"
] | [
"Vesicles"
] | [] | [] | Supported | Enhanced | null | 3 | null | null | null | Cluster 51: Neurons - Mixed function | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 86: Retinal bipolar cells - Synaptic signal transduction | Cluster 27: Cerebellum - Synaptic function | Tissue enhanced | Detected in some | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 3 | 2 | 2 | [
"Glioblastoma Multiforme"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 12,321 | 4 |
ENSG00000169271 | HSPB3 | Heat shock protein family B (small) member 3 | [
"Q12988"
] | 5 | 54455699-54456377 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA062124"
] | [
"HSPL27"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Stress response"
] | [] | [
"Disease variant",
"Neurodegeneration",
"Neuropathy"
] | [
"Nuclear speckles"
] | [] | [] | [] | Supported | null | null | null | null | null | null | Cluster 53: Neurons - Mixed function | Cluster 37: Non-specific - mRNA processing | Cluster 46: Skeletal myocytes - Muscle structure & formation | Cluster 41: Striated muscle - Muscle contraction | Group enriched | Detected in many | 19 | Cancer enriched | Detected in many | 6 | Group enriched | Detected in many | 5 | Cell type enriched | Detected in some | 6 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Bladder Urothelial Carcinoma"
] | [
"Bladder Urothelial Carcinoma"
] | 12,322 | 1 |
ENSG00000169282 | KCNAB1 | Potassium voltage-gated channel subfamily A regulatory beta subunit 1 | [
"Q14722"
] | 3 | 156037701-156539138 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA036110",
"HPA044550"
] | [
"AKR6A3",
"hKvb3",
"hKvBeta3",
"KCNA1B",
"Kvb1.3"
] | [
"Predicted intracellular proteins",
"Transporters"
] | [
"Ion transport",
"Potassium transport",
"Transport"
] | [
"Oxidoreductase"
] | [] | [
"Vesicles"
] | [
"Nucleoplasm",
"Plasma membrane"
] | [] | [] | Approved | Approved | null | 2 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 33: Neurons - Mixed function | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 105: Non-specific - Mixed function | Cluster 74: Non-specific - Signal transduction | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in some | null | Low immune cell specificity | Detected in single | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,323 | 7 |
ENSG00000169288 | MRPL1 | Mitochondrial ribosomal protein L1 | [
"Q9BYD6"
] | 4 | 77862830-77952785 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA043656"
] | [
"BM022"
] | [
"Predicted intracellular proteins",
"Ribosomal proteins"
] | [] | [
"Ribonucleoprotein",
"Ribosomal protein"
] | [] | [
"Mitochondria"
] | [] | [] | [] | Approved | Supported | null | 64 | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 14: Neurons - Synaptic function | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 52: Non-specific - Cellular respiration | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 12,324 | 2 |
ENSG00000169291 | SHE | Src homology 2 domain containing E | [
"Q5VZ18"
] | 1 | 154469772-154502412 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA037417"
] | [] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Approved | null | 1 | null | null | Cluster 8: Plasmacytoid DCs - Unknown function | Cluster 47: Endothelial cells - Vasculature | Cluster 11: Neuronal - Sensory perception | Cluster 12: Endothelial cells - Angiogenesis & vascular homeostasis | Cluster 14: Adipose tissue - Angiogenesis | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in some | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 12,325 | 3 |
ENSG00000169299 | PGM2 | Phosphoglucomutase 2 | [
"Q96G03"
] | 4 | 37826660-37862937 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA040676"
] | [
"FLJ10983"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Carbohydrate metabolism",
"Glucose metabolism"
] | [
"Isomerase"
] | [] | [
"Intermediate filaments"
] | [
"Cytosol"
] | [] | [] | Approved | Uncertain | null | 11 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 35: Non-specific - DNA binding | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 11: Muller glia cells - Retinal homeostasis | Cluster 81: Squamous epithelium - Keratinization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 5 | 0 | 5 | [
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Lung Adenocarcinoma",
"Ovary Serous Cystadenocarcinoma"
] | [
"Colon Adenocarcinoma",
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 12,327 | 5 |
ENSG00000169302 | STK32A | Serine/threonine kinase 32A | [
"Q8WU08"
] | 5 | 147234963-147387855 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA040236"
] | [
"MGC22688",
"YANK1"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [] | [
"Centrosome"
] | [] | [] | [] | Approved | null | null | 1 | null | null | null | Cluster 41: Monoamines - Neurotransmitter signalling | Cluster 9: Skin cancer - Melanin biosynthesis | Cluster 91: Pituicytes/FSC - Homeostasis & neuron support | Cluster 4: Adrenal gland - Steroid metabolism | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Lung Adenocarcinoma"
] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe",
"Lung Adenocarcinoma"
] | 12,328 | 8 |
ENSG00000169306 | IL1RAPL1 | Interleukin 1 receptor accessory protein like 1 | [
"Q9NZN1"
] | X | 28587446-29956718 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"IL1R8",
"IL1RAPL",
"MRX10",
"MRX21",
"MRX34",
"OPHN4",
"TIGIRR-2"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Plasma proteins",
"Potential drug targets",
"Predicted membrane proteins"
] | [] | [
"Hydrolase",
"Receptor"
] | [
"Intellectual disability"
] | [] | [] | [] | [] | null | null | null | 2 | null | null | null | Cluster 11: White matter - Signal transduction | Cluster 69: Skin cancer - ECM organization | Cluster 80: Oligodendrocytes - Myelination | Cluster 3: Oligodendrocytes - Myelination | Tissue enriched | Detected in single | 5 | Cancer enriched | Detected in some | 5 | Not detected | Not detected | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Glioblastoma Multiforme"
] | [] | [
"Glioblastoma Multiforme"
] | 12,329 | 9 |
ENSG00000169313 | P2RY12 | Purinergic receptor P2Y12 | [
"Q9H244"
] | 3 | 151336843-151384753 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA013796",
"HPA014518"
] | [
"HORK3",
"P2Y12",
"SP1999"
] | [
"Disease related genes",
"FDA approved drug targets",
"G-protein coupled receptors",
"Human disease related genes",
"Predicted membrane proteins",
"Transporters"
] | [
"Blood coagulation",
"Hemostasis"
] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [
"Disease variant",
"FDA approved drug targets"
] | [] | [] | [] | [] | null | Enhanced | null | null | null | null | Cluster 40: Monocytes - Innate immune response | Cluster 20: Macrophages & Microglia - Immune response | Cluster 65: Non-specific - Unknown function | Cluster 74: Microglia - Neuroimmunity & neuroinflammation | Cluster 3: Oligodendrocytes - Myelination | Tissue enriched | Detected in many | 5 | Cancer enhanced | Detected in single | null | Cancer enriched | Detected in some | 10 | Group enriched | Detected in many | 10 | Immune cell enhanced | Detected in some | null | 1 | 0 | 1 | [
"Lung Adenocarcinoma"
] | [] | [
"Lung Adenocarcinoma"
] | 12,330 | 4 |
ENSG00000169314 | C22orf15 | Chromosome 22 open reading frame 15 | [
"Q8WYQ4"
] | 22 | 23762990-23765863 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA019494"
] | [
"FLJ36561",
"N27C7-3"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Endoplasmic reticulum",
"Plasma membrane"
] | [] | [] | [] | Approved | null | null | 2 | null | null | Cluster 24: Non-specific - Transcription | Cluster 46: Brainstem - Mixed function | Cluster 12: Bone cancer - Neuronal signaling | Cluster 107: Ciliated cells - Cilia assembly & function | Cluster 48: Ciliated tissues - Cilium organization | Tissue enriched | Detected in some | 6 | Cancer enhanced | Detected in single | null | Cancer enhanced | Detected in single | null | Cell type enhanced | Detected in some | null | Immune cell enhanced | Detected in single | null | 0 | 0 | 0 | [] | [] | [] | 12,331 | 9 |
ENSG00000169327 | OR5AU1 | Olfactory receptor family 5 subfamily AU member 1 | [
"Q8NGC0"
] | 14 | 21148370-21159060 | Evidence at transcript level | Evidence at transcript level | Evidence at transcript level | Evidence at transcript level | [] | [] | [
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [
"Olfaction",
"Sensory transduction"
] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | null | Cluster 48: Non-specific - Mixed function | Cluster 56: Non-specific - Sensory perception | Cluster 52: Glandular & Luminal cells - Estrogen-regulated epithelial secretion | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,332 | 3 |
ENSG00000169330 | MINAR1 | Membrane integral NOTCH2 associated receptor 1 | [
"Q9UPX6"
] | 15 | 79432336-79472304 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA011545"
] | [
"KIAA1024",
"UBTOR"
] | [
"Predicted membrane proteins"
] | [
"Angiogenesis"
] | [] | [] | [
"Golgi apparatus"
] | [] | [] | [] | Approved | Uncertain | null | 5 | null | null | null | Cluster 26: Oligodendrocytes - Mixed function | Cluster 5: Rhabdoid - Unknown function | Cluster 18: Adrenal cortex cells - Steroidogensis | Cluster 4: Adrenal gland - Steroid metabolism | Tissue enhanced | Detected in some | null | Low cancer specificity | Detected in some | null | Cancer enhanced | Detected in single | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,333 | 4 |
ENSG00000169340 | PDILT | Protein disulfide isomerase like, testis expressed | [
"Q8N807"
] | 16 | 20359175-20404737 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA041913"
] | [
"PDIA7"
] | [
"Predicted intracellular proteins"
] | [
"Differentiation",
"Spermatogenesis"
] | [
"Chaperone",
"Developmental protein",
"Isomerase"
] | [] | [] | [] | [
"Intracellular and membrane"
] | [
"Developmental protein"
] | null | Approved | null | null | null | null | Cluster 30: Non-specific - DNA binding | Cluster 48: Non-specific - Mixed function | Cluster 15: Kidney cancer - Membrane components | Cluster 33: Early spermatids - Spermiogenesis: Cap phase | Cluster 21: Testis - Mixed function | Tissue enriched | Detected in some | 7 | Not detected | Not detected | null | Low cancer specificity | Detected in single | null | Group enriched | Detected in some | 4 | Immune cell enhanced | Detected in single | null | 0 | 0 | 0 | [] | [] | [] | 12,334 | 4 |
ENSG00000169344 | UMOD | Uromodulin | [
"P07911"
] | 16 | 20333051-20356301 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB009446",
"HPA043420",
"HPA054721"
] | [] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted membrane proteins",
"Predicted secreted proteins"
] | [
"Immunity",
"Innate immunity"
] | [] | [
"Ciliopathy",
"Disease variant",
"Nephronophthisis"
] | [] | [] | [
"Secreted in other tissues"
] | [
"Immunity"
] | null | Enhanced | null | null | null | null | null | null | Cluster 10: Ciliated cells - Ion channel activity | Cluster 50: Renal epithelial cells - Ion transport and pH regulation | Cluster 72: Kidney - Transmembrane transport | Tissue enriched | Detected in some | 515 | Not detected | Not detected | null | Group enriched | Detected in some | 16 | Cell type enriched | Detected in some | 12 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,335 | 6 |
ENSG00000169347 | GP2 | Glycoprotein 2 | [
"P55259"
] | 16 | 20309574-20327808 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA015739",
"HPA016668"
] | [
"ZAP75"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Predicted secreted proteins"
] | [
"Immunity",
"Innate immunity"
] | [
"Receptor"
] | [] | [] | [] | [
"Secreted to digestive system"
] | [
"Receptor"
] | null | Enhanced | null | null | null | null | null | Cluster 48: Non-specific - Mixed function | Cluster 27: Breast cancer - Unknown function | Cluster 5: Pancreatic acinar cells - Pancreatic exocrine secretion | Cluster 8: Pancreas - Proteolysis | Tissue enriched | Detected in many | 968 | Cancer enhanced | Detected in some | null | Cancer enriched | Detected in many | 11 | Cell type enriched | Detected in some | 39 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,336 | 7 |
ENSG00000169359 | SLC33A1 | Solute carrier family 33 member 1 | [
"O00400"
] | 3 | 155821024-155854456 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA042430"
] | [
"ACATN",
"AT-1",
"AT1",
"SPG42"
] | [
"Disease related genes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted membrane proteins",
"Transporters"
] | [
"Transport"
] | [] | [
"Cataract",
"Deafness",
"Disease variant",
"Hereditary spastic paraplegia",
"Neurodegeneration"
] | [
"Vesicles",
"Cytosol"
] | [] | [] | [] | Approved | Uncertain | null | 16 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 50: Non-specific - Nucleic acid binding | Cluster 63: Non-specific - Protein processing | Cluster 22: Non-specific - Basic cellular functions | Cluster 38: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 12,337 | 3 |
ENSG00000169371 | SNUPN | Snurportin 1 | [
"O95149"
] | 15 | 75598083-75626469 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB005004",
"HPA069478"
] | [
"RNUT1",
"SNURPORTIN-1",
"Snurportin1"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"Transport"
] | [
"RNA-binding"
] | [
"Disease variant",
"Limb-girdle muscular dystrophy"
] | [
"Nucleoplasm",
"Plasma membrane",
"Cytosol"
] | [] | [] | [] | Supported | Approved | null | 18 | null | null | Cluster 30: Non-specific - DNA binding | Cluster 14: Neurons - Synaptic function | Cluster 58: Non-specific - Nuclear processes | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 56: Ciliated tissues - Cilium organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 12,338 | 4 |
ENSG00000169372 | CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | [
"P78560"
] | 12 | 93677375-93894840 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"CAB005337"
] | [
"RAIDD"
] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Apoptosis"
] | [] | [
"Cancer-related genes",
"Disease variant",
"Intellectual disability",
"Lissencephaly"
] | [
"Cytosol"
] | [
"Nucleoplasm"
] | [] | [] | Approved | Uncertain | null | 13 | null | null | Cluster 45: Eosinophils - Unknown function | Cluster 19: Astrocytes - Mixed function | Cluster 6: Leukemia - Signal transduction | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 12,339 | 5 |
ENSG00000169375 | SIN3A | SIN3 transcription regulator family member A | [
"Q96ST3"
] | 15 | 75369379-75455842 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB004506",
"HPA047213",
"HPA062123"
] | [
"DKFZP434K2235",
"KIAA0700"
] | [
"Cancer-related genes",
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Biological rhythms",
"Transcription",
"Transcription regulation"
] | [
"Repressor"
] | [
"Cancer-related genes",
"Disease variant",
"Dwarfism",
"Intellectual disability"
] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | Enhanced | null | 149 | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 15: Non-specific - Transcription | Cluster 58: Non-specific - Nuclear processes | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 39: Testis - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 12,340 | 2 |
ENSG00000169379 | ARL13B | ADP ribosylation factor like GTPase 13B | [
"Q3SXY8"
] | 3 | 93980139-94055678 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA048926"
] | [
"ARL2L1",
"DKFZp761H079",
"JBTS8"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [] | [
"Ciliopathy",
"Disease variant",
"Joubert syndrome"
] | [
"Microtubules",
"Primary cilium",
"Primary cilium transition zone"
] | [
"Cytokinetic bridge",
"Basal body",
"Acrosome",
"Equatorial segment",
"Mid piece",
"Principal piece",
"End piece"
] | [] | [] | Supported | Approved | null | 127 | Yes | null | Cluster 14: Non-specific - Unknown function | Cluster 8: Immune cells - Immune response | Cluster 3: Rhabdoid - Membrane components | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 42: Retina - Visual perception | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma"
] | 12,341 | 2 |
ENSG00000169385 | RNASE2 | Ribonuclease A family member 2 | [
"P10153"
] | 14 | 20955487-20956436 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA044983"
] | [
"EDN",
"RAF3",
"RNS2"
] | [
"Enzymes",
"Plasma proteins",
"Predicted secreted proteins"
] | [
"Chemotaxis"
] | [
"Endonuclease",
"Hydrolase",
"Lyase",
"Nuclease"
] | [] | [] | [] | [
"Secreted to blood"
] | [
"Enzyme"
] | null | Enhanced | null | 1 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 20: Macrophages & Microglia - Immune response | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 15: Bone marrow - Innate immune response | Tissue enriched | Detected in many | 48 | Cancer enriched | Detected in single | 210 | Cancer enriched | Detected in many | 7 | Group enriched | Detected in some | 13 | Group enriched | Detected in many | 5 | 2 | 0 | 2 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 12,342 | 2 |
ENSG00000169397 | RNASE3 | Ribonuclease A family member 3 | [
"P12724"
] | 14 | 20891385-20892348 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA056183"
] | [
"ECP",
"RAF1",
"RNS3"
] | [
"Predicted secreted proteins"
] | [] | [
"Antibiotic",
"Antimicrobial",
"Endonuclease",
"Hydrolase",
"Nuclease"
] | [] | [] | [] | [
"Secreted to blood"
] | [
"Enzyme"
] | null | Enhanced | null | null | null | null | Cluster 29: Non-specific - Unknown function | Cluster 22: Non-specific - Mixed function | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 15: Bone marrow - Innate immune response | Tissue enriched | Detected in some | 95 | Cancer enriched | Detected in single | 42 | Cancer enriched | Detected in single | 8 | Group enriched | Detected in some | 9 | Immune cell enriched | Detected in many | 20 | 0 | 0 | 0 | [] | [] | [] | 12,344 | 5 |
ENSG00000169398 | PTK2 | Protein tyrosine kinase 2 | [
"Q05397"
] | 8 | 140657900-141002216 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA001842",
"CAB004036",
"HPA029671"
] | [
"FADK",
"FAK",
"FAK1",
"PPP1R71"
] | [
"Cancer-related genes",
"Disease related genes",
"Enzymes",
"Essential proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Angiogenesis"
] | [
"Developmental protein",
"Kinase",
"Transferase",
"Tyrosine-protein kinase"
] | [
"Cancer-related genes"
] | [
"Focal adhesion sites"
] | [
"Vesicles",
"Primary cilium",
"Primary cilium tip",
"Cytosol"
] | [] | [] | Supported | Approved | null | 110 | null | Yes | Cluster 34: B-cells - Unknown function | Cluster 11: White matter - Signal transduction | Cluster 40: Non-specific - Unknown function | Cluster 12: Endothelial cells - Angiogenesis & vascular homeostasis | Cluster 3: Oligodendrocytes - Myelination | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in many | null | 4 | 2 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Chromophobe",
"Pancreatic Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 12,345 | 4 |
ENSG00000169402 | RSPH10B2 | Radial spoke head 10 homolog B2 | [
"B2RC85"
] | 7 | 6754103-6799365 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA049182"
] | [] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Primary cilium"
] | [
"Plasma membrane",
"Microtubules",
"Cytosol"
] | [] | [] | Approved | Supported | null | null | null | null | null | Cluster 3: Choroid plexus - Cilium | null | Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization | Cluster 56: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in some | null | Not detected | Not detected | null | Cancer enhanced | Detected in single | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,346 | 2 |
ENSG00000169403 | PTAFR | Platelet activating factor receptor | [
"P25105"
] | 1 | 28147166-28193936 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA027543"
] | [] | [
"FDA approved drug targets",
"G-protein coupled receptors",
"Predicted membrane proteins",
"Transporters"
] | [
"Chemotaxis"
] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [
"FDA approved drug targets"
] | [
"Plasma membrane"
] | [
"Nucleoplasm",
"Vesicles"
] | [] | [] | Supported | Approved | null | 26 | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 20: Macrophages & Microglia - Immune response | Cluster 49: HMC-1 - Innate immune response | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 5 | 0 | 0 | 0 | [] | [] | [] | 12,347 | 5 |
ENSG00000169410 | PTPN9 | Protein tyrosine phosphatase non-receptor type 9 | [
"P43378"
] | 15 | 75463251-75579315 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041922"
] | [
"MEG2"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase",
"Protein phosphatase"
] | [] | [
"Vesicles"
] | [] | [] | [] | Approved | Approved | null | 43 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 58: Non-specific - Nuclear processes | Cluster 105: Non-specific - Mixed function | Cluster 77: Intestine - Digestion | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Colon Adenocarcinoma"
] | [
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 12,348 | 8 |
ENSG00000169413 | RNASE6 | Ribonuclease A family member k6 | [
"Q93091"
] | 14 | 20781268-20782467 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA000698"
] | [
"RAD1",
"RNaseK6",
"RNS6"
] | [
"Predicted secreted proteins"
] | [] | [
"Antibiotic",
"Antimicrobial",
"Endonuclease",
"Hydrolase",
"Nuclease"
] | [] | [] | [] | [
"Secreted to blood"
] | [
"Enzyme"
] | null | Approved | null | null | null | null | Cluster 2: Dendritic cells - Unknown function | Cluster 20: Macrophages & Microglia - Immune response | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 82: Dendritic cells - Antigen presentation | Cluster 18: Lymphoid tissue - Immune response | Tissue enhanced | Detected in all | null | Group enriched | Detected in some | 4 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Immune cell enhanced | Detected in all | null | 1 | 0 | 1 | [] | [
"Testicular Germ Cell Tumor"
] | [
"Testicular Germ Cell Tumor"
] | 12,349 | 6 |
ENSG00000169418 | NPR1 | Natriuretic peptide receptor 1 | [
"P16066"
] | 1 | 153678688-153693992 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA031087"
] | [
"ANPa",
"ANPRA",
"GUCY2A",
"NPRA"
] | [
"Enzymes",
"FDA approved drug targets",
"Metabolic proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"cGMP biosynthesis"
] | [
"Lyase",
"Receptor",
"Vasoactive"
] | [
"FDA approved drug targets"
] | [
"Nucleoli"
] | [
"Nucleoplasm",
"Plasma membrane"
] | [] | [] | Approved | null | null | 1 | null | null | null | Cluster 47: Endothelial cells - Vasculature | Cluster 44: Connective tissue cells - ECM organization | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Group enriched | Detected in all | 4 | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 7 | 0 | 7 | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Stomach Adenocarcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma",
"Stomach Adenocarcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | 12,350 | 1 |
ENSG00000169427 | KCNK9 | Potassium two pore domain channel subfamily K member 9 | [
"Q9NPC2"
] | 8 | 139600838-139704109 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA075842"
] | [
"K2p9.1",
"TASK-3",
"TASK3"
] | [
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Predicted membrane proteins",
"Transporters",
"Voltage-gated ion channels"
] | [
"Ion transport",
"Potassium transport",
"Sodium transport",
"Transport"
] | [
"Ion channel",
"Potassium channel",
"Sodium channel"
] | [
"Disease variant",
"FDA approved drug targets",
"Intellectual disability"
] | [
"Plasma membrane"
] | [] | [] | [] | Approved | null | null | null | null | null | null | Cluster 35: Non-specific - DNA binding | Cluster 16: Thyroid cancer - Neuronal signaling | Cluster 2: Cerebellar granular cells - Neuronal signaling | Cluster 71: Cerebellum - Nervous system development | Tissue enriched | Detected in some | 5 | Cancer enhanced | Detected in some | null | Cancer enriched | Detected in single | 5 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,351 | 1 |
ENSG00000169429 | CXCL8 | C-X-C motif chemokine ligand 8 | [
"P10145"
] | 4 | 73740519-73743716 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA057179"
] | [
"3-10C",
"AMCF-I",
"b-ENAP",
"GCP-1",
"GCP1",
"IL-8",
"IL8",
"K60",
"LECT",
"LUCT",
"LYNAP",
"MDNCF",
"MONAP",
"NAF",
"NAP-1",
"NAP1",
"SCYB8",
"TSG-1"
] | [
"Cancer-related genes",
"Candidate cardiovascular disease genes",
"Plasma proteins",
"Predicted secreted proteins"
] | [
"Chemotaxis",
"Inflammatory response"
] | [
"Cytokine"
] | [
"Cancer-related genes"
] | [
"Golgi apparatus"
] | [] | [
"Secreted to blood"
] | [
"Chemokine"
] | Approved | Supported | null | 6 | null | null | Cluster 4: Neutrophils - Degranulation | Cluster 12: Non-specific - Vasculature | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 31: Neutrophils - Chemotaxis & Apoptosis | Cluster 15: Bone marrow - Innate immune response | Tissue enriched | Detected in many | 7 | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in some | 408 | 3 | 0 | 3 | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 12,352 | 1 |
ENSG00000169435 | RASSF6 | Ras association domain family member 6 | [
"Q6ZTQ3"
] | 4 | 73571550-73620631 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA037712"
] | [] | [
"Predicted intracellular proteins"
] | [
"Apoptosis"
] | [] | [] | [
"Nucleoplasm",
"Golgi apparatus"
] | [] | [] | [] | Approved | Approved | null | 9 | null | null | Cluster 17: B-cells - Immunoglobulins | Cluster 36: Choroid plexus - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 95: Tuft cells - Chemosensory signaling | Cluster 60: Stomach - Digestion | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in single | 8 | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,354 | 4 |
ENSG00000169436 | COL22A1 | Collagen type XXII alpha 1 chain | [
"Q8NFW1"
] | 8 | 138588235-138914041 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA024830"
] | [] | [
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [] | [] | [
"Vesicles"
] | [
"Endoplasmic reticulum"
] | [
"Secreted to extracellular matrix"
] | [
"No annotated function"
] | Approved | Enhanced | null | null | null | null | null | Cluster 43: Hindbrain - Mixed function | Cluster 10: Ciliated cells - Ion channel activity | Cluster 59: Pituitary endocrine cells - Neuroendocrine signaling | Cluster 20: Pituitary gland - Hormone signaling | Tissue enriched | Detected in many | 6 | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 5 | 2 | 4 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | 12,355 | 6 |
ENSG00000169439 | SDC2 | Syndecan 2 | [
"P34741"
] | 8 | 96493813-96611790 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB025123",
"HPA068532",
"HPA074427"
] | [
"CD362",
"fibroglycan",
"HSPG",
"HSPG1",
"SYND2"
] | [
"CD markers",
"Predicted membrane proteins"
] | [
"Differentiation",
"Neurogenesis"
] | [] | [] | [
"Plasma membrane"
] | [] | [] | [] | Enhanced | Uncertain | null | 55 | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 21: Non-specific - Metabolism | Cluster 64: Connective tissue cells - ECM organization | Cluster 108: Fibroblasts - ECM organization | Cluster 45: Liver - Metabolism & Coagulation | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in some | 7 | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 12,356 | 1 |
ENSG00000169442 | CD52 | CD52 molecule | [
"P31358"
] | 1 | 26317958-26320523 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"CDW52",
"EDDM5",
"HE5"
] | [
"Cancer-related genes",
"CD markers",
"FDA approved drug targets",
"Predicted membrane proteins"
] | [] | [] | [
"Cancer-related genes",
"FDA approved drug targets"
] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 3: Non-specific - Nuclear processes | Cluster 23: Choroid plexus - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 30: Epididymal principal cells - Sperm storage microenvironment | Cluster 50: Epididymis - Male reproductive secretion | Tissue enriched | Detected in many | 29 | Group enriched | Detected in many | 7 | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in many | 28 | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Skin Cutaneous Melanoma"
] | [] | [
"Breast Invasive Carcinoma",
"Skin Cutaneous Melanoma"
] | 12,357 | 4 |
ENSG00000169446 | MMGT1 | Membrane magnesium transporter 1 | [
"Q8N4V1"
] | X | 135960588-135974029 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA032037"
] | [
"EMC5",
"TMEM32"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Transport"
] | [] | [] | [] | [] | [] | [] | null | Approved | null | 122 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 21: Non-specific - Metabolism | Cluster 36: Non-specific - mRNA processing | Cluster 91: Pituicytes/FSC - Homeostasis & neuron support | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Colon Adenocarcinoma"
] | [
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 12,358 | 2 |
ENSG00000169469 | SPRR1B | Small proline rich protein 1B | [
"P22528"
] | 1 | 153031203-153032900 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"GADD33",
"SPRR1"
] | [
"Cancer-related genes",
"Essential proteins",
"Predicted intracellular proteins"
] | [
"Keratinization"
] | [] | [
"Cancer-related genes"
] | [] | [] | [] | [] | null | null | null | 4 | null | null | null | null | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 84: Apical squamous epithelium - Cornification | Cluster 81: Squamous epithelium - Keratinization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enriched | Detected in many | 4 | Cell type enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 2 | 2 | 1 | [] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 12,359 | 4 |
ENSG00000169484 | OR4K14 | Olfactory receptor family 4 subfamily K member 14 | [
"Q8NGD5"
] | 14 | 20014143-20019307 | No human protein/transcript evidence | No human protein/transcript evidence | No human protein/transcript evidence | No human protein/transcript evidence | [] | [] | [
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [
"Olfaction",
"Sensory transduction"
] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | null | null | null | null | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,361 | 6 |
ENSG00000169490 | TM2D2 | TM2 domain containing 2 | [
"Q9BX73"
] | 8 | 38988808-38996824 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA047152",
"HPA050547"
] | [
"BLP1"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Nucleoplasm",
"Vesicles",
"Plasma membrane"
] | [] | [] | [] | Approved | Approved | null | 1 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 21: Non-specific - Metabolism | Cluster 40: Non-specific - Unknown function | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 1: Choroid plexus - Transmembrane transport | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 12,363 | 3 |
ENSG00000169495 | HTRA4 | HtrA serine peptidase 4 | [
"P83105"
] | 8 | 38974228-38988663 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA045402"
] | [
"FLJ90724"
] | [
"Enzymes",
"Predicted secreted proteins"
] | [] | [
"Hydrolase",
"Protease",
"Serine protease"
] | [] | [] | [] | [
"Secreted in female reproductive system"
] | [
"Enzyme"
] | null | Enhanced | null | 12 | null | null | Cluster 24: Non-specific - Transcription | Cluster 9: Non-specific - Receptor signaling | Cluster 34: Testis cancer - Unknown function | Cluster 21: Extravillous trophoblasts - Placental invasion & endocrine regulatio | Cluster 43: Placenta - Pregnancy hormone signaling | Tissue enriched | Detected in some | 10 | Cancer enriched | Detected in single | 11 | Low cancer specificity | Detected in many | null | Cell type enriched | Detected in many | 15 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Lung Adenocarcinoma"
] | [] | [
"Lung Adenocarcinoma"
] | 12,364 | 5 |
ENSG00000169499 | PLEKHA2 | Pleckstrin homology domain containing A2 | [] | 8 | 38901235-38973912 | Evidence at transcript level | Evidence at transcript level | null | null | [
"HPA004706"
] | [
"TAPP2"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm",
"Nuclear bodies",
"Cytosol"
] | [] | [] | [] | Uncertain | Approved | null | 15 | null | null | Cluster 14: Non-specific - Unknown function | Cluster 51: Neurons - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 18: Lymphoid tissue - Immune response | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma"
] | 12,365 | 8 |
ENSG00000169504 | CLIC4 | Chloride intracellular channel 4 | [
"Q9Y696"
] | 1 | 24745382-24844321 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA008019",
"HPA060804"
] | [
"CLIC4L",
"DKFZP566G223",
"H1",
"huH1",
"P64H1"
] | [
"Predicted intracellular proteins",
"Transporters"
] | [
"Ion transport",
"Transport"
] | [
"Chloride channel",
"Ion channel",
"Oxidoreductase",
"Voltage-gated channel"
] | [] | [
"Plasma membrane",
"Centrosome"
] | [
"Calyx",
"Connecting piece",
"Principal piece"
] | [] | [] | Supported | Enhanced | null | 7 | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 13: Oligodendrocytes - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 12: Endothelial cells - Angiogenesis & vascular homeostasis | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Lung Adenocarcinoma"
] | 12,366 | 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.